UniProtKB/Swiss-Prot P15382: Variant p.Val109Ile

Potassium voltage-gated channel subfamily E member 1
Gene: KCNE1
Feedback?

Variant information Variant position:

109 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Valine (V) to Isoleucine (I) at position 109 (V109I, p.Val109Ile). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In LQT5; uncertain significance; no effect on KCNQ1 C-terminus interaction; increases cAMP-mediated up-regulation of the I(KS) current; no effect on phosphorylation at S27. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs77442996 [ dbSNP | Ensembl ]

Sequence information Variant position:

109 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

129 The length of the canonical sequence.
Location on the sequence:

EKDKAYVQARVLESYRSCYV V ENHLAIEQPNTHLPETKPSP The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         EKDKAYVQARVLESYRSCYVVENHLAIEQPNTHLPETKPSP

Mouse                         EKGKAVFQARVLESFRACYVIENQAAVEQPATHLPELKPLS

Rat                           EKGKALFQARVLESFRACYVIENQAAVEQPATHLPELKPLS

Pig                           EKGKALFQARVLESFRACYAIENQAAVEQPATHLPELKPLS

Rabbit                        EKDRAYFQARVLESCRGCYVLENQLAVEHPDTHLPELKPSL

Cat                           EKDKAYLQARVLESYKACYVIENQLAVERPNAHLPEIKPLS

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 129	Potassium voltage-gated channel subfamily E member 1
Topological domain	67 – 129	Cytoplasmic
Region	109 – 129	interaction with KCNQ1 C-terminus
Modified residue	102 – 102	Phosphoserine; by PKC
Mutagenesis	109 – 129	Missing. Totally suppressed interaction with KCNQ1 C-terminus.

Literature citations
A novel long-QT 5 gene mutation in the C-terminus (V109I) is associated with a mild phenotype.
Schulze-Bahr E.; Schwarz M.; Hauenschild S.; Wedekind H.; Funke H.; Haverkamp W.; Breithardt W.; Pongs O.; Isbrandt D.; Breithardt G.;
J. Mol. Med. 79:504-509(2001)
Cited for: VARIANT LQT5 ILE-109; Long QT mutations at the interface between KCNQ1 helix C and KCNE1 disrupt I(KS) regulation by PKA and PIP(2).
Dvir M.; Strulovich R.; Sachyani D.; Ben-Tal Cohen I.; Haitin Y.; Dessauer C.; Pongs O.; Kass R.; Hirsch J.A.; Attali B.;
J. Cell Sci. 127:3943-3955(2014)
Cited for: CHARACTERIZATION OF VARIANTS LQT5 ILE-109 AND THR-127; MUTAGENESIS OF 109-VAL--PRO-129;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.